Lucy Vereshchagina, Ph.D.

Vice President,
Science & Regulatory Advocacy, PhRMA

Dr. Vereshchagina is the vice president, science and regulatory advocacy at the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA represents the country’s leading innovative biopharmaceutical research companies, which are devoted to researching and developing medicines that enable patients to live longer, healthier, and more productive lives. She leads the regulatory advocacy team with the focus on the Prescription Drug User Fee Act (PDUFA), the Biosimilar User Fee Act (BsUFA), as well as other regulatory policy and advocacy issues. Dr. Vereshchagina was the lead PhRMA negotiator for both PDUFA VII and BsUFA III and testified before Congress on the agreements’ reauthorization.